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Summary Background: Adipose-derived stem cells (ADSC) can be readily extracted from ad-
ipose tissue, expanded in vitro, and have the capacity to differentiate into multiple cell line-
ages. This makes this cell type of great interest to the field of regenerative medicine. This
study focuses on the isolation and characterisation of ADSC and their differentiation into ad-
ipocytes in a 3D microtissue model.
Methods: Human ADSC were isolated from abdominal adipose tissue and characterised using
multiparameter flow cytometry. ADSC were then expanded in culture and used to produce
3D scaffold-free micro-tissue. Adipogenic differentiation potential of micro-tissue constructs
were subsequently characterised using Oil Red O staining.
Results: Flow cytometric analysis showed ADSC were uniformly positive for CD34, CD73, CD90,
and CD105, and negative for CD19, CD14, and CD45. The cells were functionally induced into
adipocytes in the presence of appropriate conditioned media.
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Conclusion: We have demonstrated that adipose-derived stem cells have the ability to form of
microtissue and survive in vitro. We postulate that in the future this will result in an ADSC pop-
ulation which is injectable and can extend the delivery options of current stem cell-based
therapies.
ª 2014 Published by Elsevier Ltd on behalf of British Association of Plastic, Reconstructive and
Aesthetic Surgeons.
Introduction
Adipose tissue is used as an autologous filler for soft-tissue
defects, following trauma, birth defects, and oncologic
resection.1,2 Autologous fat transfer has the advantage of
using the patient’s own tissue with minimal donor-site
morbidity and eliminating the issues of foreign body reac-
tion or rejection.
In recent years, fat transfer has become increasingly
interesting to the plastic surgeon, used for indications such
as facial volume replacement,3 cosmetic breast augmen-
tation,4 correction of congenital breast abnormalities,5
chronic wounds6 and cutaneous radiation syndromes.7 Fat
transfer has also been shown in an animal model to accel-
erate revascularisation and decrease fibrosis following
thermal injury.8 The ASAPS/ASPS position statement in
20129 gives a succinct overview of the issues surrounding
contemporary fat transfer and stem cell therapies, and
acknowledges the need for increased efforts into both basic
science investigations and translation into evidence based
clinical therapies.
When replacing volume, fat graft survival is one of the
major problems, with long term follow up studies revealing
20e70% volume loss.10e15 The lack of revascularisation of
grafts commonly underpins the problem, and this is
particularly a problem in breast reconstruction where
larger volumes of fat are required. The result is that mul-
tiple procedures are required, with increased direct and
hidden financial and emotional costs.
Adipose-derived stem cells (ADSC) are an area of inter-
est for plastic and reconstructive surgeons at present as
they can differentiate to specialized cells,16e18 enhance
angiogenesis and minimise inflammation.19 ADSC have
similar characteristics to bone marrow-derived mesen-
chymal stem cells (BMSC),20e24 contain 100e1000X more
MSC per cm326 and are easier to isolate. ADSC are identified
by plastic adhesion, immunophenotypic profile, cell
morphology, and multilineage differentiation.16,25 Due to
these factors, ADSC have been the focus of much investi-
gational work in recent years,27,28 differentiated down all
mesenchymal cell lines28 and are easily expanded in
vitro.29 Current lines of investigation include techniques to
improve graft survival and methods of delivery. Scaffold-
free cell delivery is an area of interest for regenerative
medicine research including three main techniques: single
cell, cell sheet engineering and micro-tissue.30 Micro-tissue
is a 3D scaffold free cell aggregate using spheroid cultures,
and has been referred to as multi-cellular spheroids,
micromasses or microspheres in the literature.31 Engi-
neered micro-tissue constructs have been developed for
targeted nervous system reconstruction with living axons,
dermal substitution,35 and vessel36 and cartilage37 recon-
struction. The basic advantages of multi-cellular spheres
over 2D monolayer cultures are the cell-to-cell and cell-to-
matrix interactions.31 Kelm and Fussennegger suggest that
‘microtissue maintains tissue specific functionality and
supports seamless integration of implants into host tis-
sues’.38 Compared to monolayer cultures, there seems to
be an accelerated differentiation of cells in microtissues.31
The induction of adipogenic differentiation in spheroid
cultures is new, therefore in this study we aimed to induce
adipogenic differentiation in 3D culture systems in vitro as
a proof of concept. The differentiation capacity between
umbilical cord and adipose-derived stem cells was also
investigated in a similar fashion to that of Hildner’s study of
micromass cultures.42
Materials and methods
Adipose tissue samples (n Z 5) were obtained from the
supra-Scarpa’s fascia abdominal tissue of patients under-
going Deep Inferior Epigastric Perforator (DIEP) flap
reconstruction (age range 31e58 years, mean Z 46 years).
Umbilical cord mesenchymal stem cells (UC-MSC) were
isolated from umbilical cord of full term placentas (nZ 4).
Approval for this study was from the South Wales Research
Ethics Committee; all participants gave written informed
consent.
Isolation of human adipose-derived stem cells
(ADSC)
ADSC were isolated according to the method described by
Zuk et al.16 with modifications. Following removal of fibrous
tissue and visible blood vessels, samples were cut into small
pieces (3 mm3) and digested in Dulbecco’s Modified Eagle’s
Medium/Nutrient Mixture F-12 Ham (DMEM/F12) containing
300 U/ml crude collagenase II (Invitrogen, Life Technologies
Ltd, Paisley, UK) for 30 min in an incubator (37 C, 5% CO2).
The dispersed material was filtered through 70 mm Cell
Strainers (BD Biosciences, Oxford, UK). After centrifugation
(290 G, 5 min), the ADSC-rich cell preparation formed a
pellet at the bottom of the tube. The supernatant was
removed and the pellet re-suspended. The number of
viable cells was determined by cell counting on a haemo-
cytometer and Trypan blue exclusion. At passage zero
1  106 cells per test tube (12 in total) were reserved for
flow cytometry analysis and the remaining cells expanded
in culture.
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Isolation of human umbilical cord mesenchymal
stem cells (UC-MSC’s)
UC-MSC were isolated according to the method described by
S. Azandeh et al. with modifications. Exposed veins and ar-
teries were removed from the Whartons Jelly (WJ). The
extracted WJ was washed twice with carrying solution and
cut into 3e5 mm3 pieces. For explant growth 6e9 pieces
were seeded into 25 cm2 T-flasks, containing DMEM/F-12
with 10% FBS and 1% antibiotic and incubated (37 C, 5%CO2).
Culture and expansion
Cells were cultured for up to 2 passages (Figure 1). At each
subsequent passage, cells were seeded to sub-confluence in
75 cm2 culture flasks for 7e10 days at a cell density of
3  104 per cm2. When the cells reached approximately 80%
confluence, subculture was performed through trypsiniza-
tion. The cell suspension was centrifuged (290 g, 5 min),
the pellet was resuspended and cells were counted as
before. After each passage, 5  105 cells per test tube were
reserved for flow cytometry (12 in total for ADSC only) and
the remaining cells seeded in new 75 cm2 flasks at
3  105 cells per flask and incubated (37 C, 5% CO2).
Immunophenotypic characterization of ADSC
ADSC from passage 0 to 2 were used for immunophenotypic
characterization using flow cytometry. ADSC were stained
with antibodies for different CD (cluster of differentiation)
antigens and HLA-DR (Table 1 and Table 2). None of the
antibodies were further diluted. 6  106 cells at passage 1
onwards and 1.2  107 cells at passage 0 were suspended in
0.2 ml PBS and incubated with the antibodies for 30 min on
ice and protected from light. At each analysis a separate
tube was used for every antibody to provide compensation
controls, one sample tube contained all antibodies, 2
sample tubes contained unstained cells as controls, and one
tube contained the isotype controls. Subsequently, Easy-
Lyse solution was used to lyse the red blood cells e 3 mls of
1:20 Erythrocyte-Lysing Reagent EasyLyse (BD Biosciences,
Oxford, UK) in distilled water was added to each tube, left
in the dark at room temperature for 15 min, and then
centrifuged at 515 g for 7 min at 5 C. The supernatant
was then removed, 3 mls of FACS buffer (PBS/0.2% BSA/
0.05% sodium azide) added, and each tube was centrifuged
at 515 g, 5 C for 7 min again. The supernatant was again
removed and 200 ml of 1:3 diluted FACS fix solution (BD
Biosciences, Oxford, UK) in distilled water was added. The
samples were acquired by flow cytometry (FACSAria I; BD
Biosciences, Oxford, UK) within 24 h. Kaluza software
(version 1.2; Beckman Coulter, USA) was used to analyse
the data.
Micro-tissue production
UC-MSC and ADSC were seeded into 75 cm2 tissue culture
flasks in DMEM-F12 containing glutamate (Life Technologies
Table 1 Flow cytometry antibodies. FITC: fluorescein isothiocyanate, PerCP: peridinin-chlorophyll proteins, APC: allophy-
cocyanin, PE: phycoerythrin.
CD45 CD34 CD19 HLA-DR CD14 CD73 CD90 CD105
Source BD Biosciences,
New Jersey, USA
eBioscience, San Diego, USA Miltenyi Biotec,
Germany
eBioscience, San Diego, USA
Fluorescent dye FITC PerCP APC-eFluor 780 PerCP-eFluor 710 VioGreen eFluor 450 APC PE
Excitation wave
length (nm)
490 482 633 488 405 409 650 496
Table 2 Flow cytometry voltage configurations. FSC:
forward scatter, SSC: side scatter, FITC: fluorescein iso-
thiocyanate, PE: phycoerythrin, APC: allophycocyanin,
PerCP: peridinin-chlorophyll proteins, BDV500: BD Horizon
V500.
Flow Cytometry Configuration
Parameters Voltage
FSC 0
SSC 269
FITC 385
PE 440
APC 610
Alexa Fluor 780 632
BDV500 341
eFluor 450 390
PerCP-Cy 5.5 571
PE-Cy7 786
Figure 1 Light microscope image of sub-confluent ADSC at
passage 2. 10 magnification showing spindle-shaped plastic-
adherent ADSC.
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Ltd, Paisley, UK), 10% FCS, 1% antibiotic and incubated
(37 C, 5% CO2). Cultures were fed every 3e5 days until
cells reached 70e80% confluence. Cells were then trypsi-
nised and resuspended into 60 well Terasaki plates (Griener
BioOne, Stonehouse, Gloucestershire, UK) at the seeding
density of 2  103 cells (in 20 ml) per well and incubated
upside-down overnight to form microtissue in hanging drops
(Figure 4).
Live-cell fluorescent staining
The relative locations of DNA in all cells, intra-plasmatic
esterase in live cells, and nucleic acids in dead cells within
micro-tissues were visualized via staining with the fluores-
cent dyes Hoechst 33342, Calcein AM, and Propidium Iodide
(PI), respectively (Life Technologies Ltd, Paisley, UK). The
micro-tissue samples were incubated with serum-free
DMEM-F12 containing 5 ml/ml of 5 mg/ml Hoechst 33342,
0.5 ml/ml of 4 mM Calcein AM, and 1 ml/ml of 1 mg/ml PI
fluorescent dyes for 15 min. Stained cells were imaged by
confocal microscopy with an excitation/detection of 352/
461 nm, 495/515 nm, and 535/617 nm, respectively.
Adipose differentiation, Oil Red O and DiI staining
Adipose tissue differentiation media containing Dexa-
methasone (1 mM), 3-isobutyl-1-methylxanthine (0.5 mM),
Indomethacin (60 mM), Insulin (10 mg/ml) and Hydrocorti-
sone (0.5 mM) was used for the experiments. For adipose
differentiation, the microtissues formed from hanging
drops were moved to a U-bottom 96 well plate (Griener
BioOne, Stonehouse, UK). Adipose differentiation was
assessed at 7, 10, and 14 days using Oil red O staining and
light microscopy. Due to the possibility of microtissue
dissociation in 2D or U-bottom plate cultures, a rotator was
used to sustain 3D culture. The contents of twenty wells
containing micro-tissues were transferred from the Ter-
asaki plates in a centrifuge tube and incubated in a Ruskinn
Figure 3 CD antigen expression at P1. ADSC expressed CD73, CD90, CD105, CD34, and lacked CD14, CD19, CD45 and HLA-DR
expression. A small population of contaminating macrophages was observed which was CD45 and HLA-DR positive.
Figure 2 Flow cytometry analysis at P0 and P1. A) At P0 five separate cell populations were identified. B) At P1 only 1 population
remained identifiable.
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Figure 5 Micro-tissue formation from ADSC 1 day after incubation. Confocal microscopy of A) Hoechst 33342 (blue) for cell
nuclei, B) Calcein AM (green) for living cells, and C) PI stained (red) for dead cells. D) Merged image of the three stains.
Figure 4 Diagram of microtissue preparation.
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SCI-tive Dual system (Ruskinn Technology Ltd, Bridgend,
UK). A Mini LabRoller, Labnet (Appleton Woods Ltd, Bir-
mingham, UK) was used to rotate the centrifuge tubes
containing microtissue for continuous culture. Adipose
differentiation was assessed at day 7 using DiI (Life Tech-
nologies Ltd, Paisley, UK) fluorescent staining for lipids and
observed by confocal microscopy. All cultures were rinsed
in PBS and fixed in 10% buffered formalin for 1 h. A 0.5%
stock solution of Oil Red O in 100% isopropanol (50mg/
10 ml) was prepared. Cultures were rinsed in 60% iso-
propanol, immersed in a working solution of Oil Red O for
30 min and subsequently washed several times in distilled
water.
For fluorescent staining of microtissues, 5 ml/ml of 5 mg/
ml Hoechst 33342, 0.5 ml/ml of 4 mM Calcein AM were used
to stain living cells and a lipophilic dye, DiI (Life Technol-
ogies Ltd, Paisley, UK) was used to stain lipids for 30 min.
Quantification of Oil Red O staining
Isolated ADSC (n Z 5) were differentiated into adipocytes
or grown in culture in control media. The level of Oil Red O
staining was quantified by dissolving the stained fat in 100%
isopropanol for 15 min. The plates were centrifuged at
1000 rpm for 10 s and the supernatant taken for spectro-
scopic analysis using the Polarstar Omega plate reader
(BMG Laboratories, UK). Absorbance was read at 500 nm.
The student T-test (Microsoft Excel software) was used to
show statistical significance in the difference of Oil Red O
staining between the differentiated ADSC and controls.
Results
Isolation and flow cytometry characterisation
Cellular surface markers on passage 0, 1, and 2 cells were
analyzed in order to characterize the cell populations. At
passage 0, five different cell populations were consistently
identifiable (Figure 2A), whilst only a single cell population
remained at passages 1 and 2 (Figure 2B). At passage 0 each
population showed a different CD expression profile. Only
one population remained throughout the passages and this
was uniformly CD34þ/CD73þ/CD90þ/CD105þ/CD19/
CD14/CD45 (Figure 3) and capable of undergoing adipo-
genesis in vitro based on Oil Red O staining (Figure 6B and
D).
Live-cell fluorescent staining of micro-tissues
Confocal microscopy images of Hoechst, Calcein AM, and PI
stained micro-tissue formed 1 day after incubation of ADSC
showed good cell viability, with micro-tissue diameters of
around 100 mm (Figure 5AeD).
Adipose differentiation
ADSC and UCM-MSC micro-tissues were cultured in adipose
differentiation medium (ADM), Cells in microtissue were
dissociated in U-bottom tissue culture plates during the
course of culture. Adipose differentiation was assessed at
Figure 6 Lipid formation in ADSC compared to UCM-MSC in U-bottom 96 well plate culture system demonstrated using Oil Red O
staining and light microscopy. A) ADSC in ADM for 10 days, lipid droplets (LD) are visible. B) Oil red O staining of ADSC in ADM for 10
days showing large red lipid droplets (LD). C) UCM-MSCs in ADM for 14 days, no visible lipid droplets observed. D) Oil red O staining
of UCM-MSCs in ADM for 14 days showing only very fine lipid droplets (LD).
Adipogenic differentiation of adipose-derived stem cells 1731
7, 10, and 14 days using fluorescent Oil red O staining and
light microscopy. We have demonstrated that ADSC from
micro-tissue can successfully differentiate into adipocytes
(Figure 6A and B) and have developed a protocol for adipose
tissue differentiation. Our results illustrate that ADSC had a
better potential of adipose differentiation (Figure 6A and B)
compared to UCM-MSC (Figure 6C and D). In 3D culture using
a Ruskinn stem cell station and a rotating bioreactor
in vitro, we demonstrated that ADSC differentiated into
adipose cells within microtissue using DiI lipophilic fluo-
rescent staining (Figure 7A and B). Using Calcein AM stain-
ing for living cells we demonstrated that most cells in
microtissue remained viable after 7 days in 3D culture
(Figure 7).
Oil Red O staining of differentiated cells was signifi-
cantly higher (p Z 0.0024) than that of the undifferenti-
ated control cells (Figure 8).
Discussion
As aforementioned, human ADSC can be readily harvested
from adipose tissue using standard techniques16 and have
high proliferation rates for in vitro expansion with multi-
lineage differentiation capacity.24 There is considerable
contemporary interest in the applications of human ADSC,
and there are many ongoing clinical trials regarding their
use. A variety of methods have been developed to harvest
these cells, but the purity of isolated ADSC remains an
issue. The Cytori Therapeutics’ Celution system (Cytori
Therapeutics Inc., San Diego, CA, USA), for example, iso-
lates a heterogenous population of cells with fractions of
ADSC that are ‘cell enriched’ rather than specifically ‘stem
cell enriched’.43 To date there is no ideal method for
identification of ADSC from the SVF. Several groups are
Figure 7 Adipose differentiation in a 3D rotating culture system. A) ADSC micro-tissue in control culture medium for 1 week. B)
Lipid staining (red) of ADSCs in ADM for 1 week. Notice the red lipid droplet (LD) formation. C) UCM-MSC in control culture media for
1 week. Micro-tissue grows in size. D) UCM-MSCs in ADM for 1 week. Formation of only very fine lipid droplets (LD) observed.
Figure 8 Oil Red O staining quantification of adipogenic
differentiated ADSC compared to undifferentiated ADSC con-
trols (n Z 5) (p Z 0.0024).
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currently investigating identification methods and mecha-
nisms to isolate and purify ADSC.44e46 We used a simple and
effective way to obtain ADSC by using collagenase diges-
tion. Since no unique molecular marker for mesenchymal
stem cells has been established we used multi-parameter
flow cytometry for the identification of ADSC. ADSC
showed consistent expression of CD73, CD90, CD105 (known
mesenchymal stem cell markers), and CD34 contrasting
with the lack of expression of haematopoietic cell markers
CD14, CD19, CD45, and HLA-DR. There was a small subset of
HLA-DR positive cells present at passage 1 which were
identified as microphages and were no longer present at
passage 2. CD34 expression in early culture of mesenchymal
stem cells is well documented, although loss of expression
does occur in later passages.47e50
Our results provide preliminary in vitro evidence that
mesenchymal stem cells derived from human adipose tissue
can be grown as floating micro-tissue spheres through
several passages. In the present study, we plated cells from
freshly dissociated adipose tissue in preliminary monolayer
culture. Our culture process induced the loss of the vast
majority of the harvested primary stromal vascular fraction
(SVF) cells, while some of the growth factor-responsive
cells generated micro-tissues. This was evident from the
loss of 3 cell populations after several passages. ADSC have
the capacity to proliferate in non-adherent conditions and
to form medium sized micro-tissues (100e200 mm in diam-
eter). As we expected, the ADSC showed superior adipo-
genic differentiation capacity compared to UC-MSCS.
Previous studies support our putative theory that micro-
tissue culture of ADSC may enhance their biological activ-
ity, and hence be of benefit in vivo e the administration of
human ADSC increased the rate of diabetic wound healing
when ADSC were derived from aggregates, but not when
ADSC derived from monolayer culture were delivered.51
Dromard et al. developed a new culture system, which al-
lows the expansion of ADSC as spheres in a defined me-
dium40 and these spheres could be passaged several times.
They were not only aggregated cells but rather originated
from single cells as clonal spheres that can be obtained
after seeding at very low density and reform clonal spheres
after dissociation. These spheres can revert to monolayer
growth when plated in medium containing human plasma
and even generate fibroblast-like colonies. Under several
differentiation-specific media, sphere-derived ADSC main-
tained their capacity to differentiate into osteoblasts,
endothelial cells and adipocytes. There is a growing inter-
est in designing bioreactor systems that provide safe and
controlled high-density cell culture. In this context, our
results represent an important step in our ability to isolate
and maintain ADSC in culture. Our in vitro study builds on
the work of others involving different mesenchymal stem
cell lineages and shows that growth of ADSC in micro-tissue
is possible. As the induction of adipogenic differentiation in
spheroid cultures is relatively new, we believe the ability to
induce adipogenic differentiation in 3D culture systems
in vitro is of interest, 3D culture systems may enhance
biological activity and in timetool to investigate and
develop novel injectable micro-tissue preparations from
adipose-derived stem cells in the future. If successful, such
preparations would have potential as an in vivo cell de-
livery tool in soft tissue regeneration and reconstruction.
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